HK1171185A1 - Anti-tumor effect potentiator - Google Patents
Anti-tumor effect potentiatorInfo
- Publication number
- HK1171185A1 HK1171185A1 HK12111795.0A HK12111795A HK1171185A1 HK 1171185 A1 HK1171185 A1 HK 1171185A1 HK 12111795 A HK12111795 A HK 12111795A HK 1171185 A1 HK1171185 A1 HK 1171185A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- tumor effect
- effect potentiator
- potentiator
- tumor
- effect
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
- C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/513—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim having oxo groups directly attached to the heterocyclic ring, e.g. cytosine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Oncology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2009272738 | 2009-11-30 | ||
| PCT/JP2010/071280 WO2011065541A1 (ja) | 2009-11-30 | 2010-11-29 | 抗腫瘍効果増強剤 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1171185A1 true HK1171185A1 (en) | 2013-03-22 |
Family
ID=44066645
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK12111795.0A HK1171185A1 (en) | 2009-11-30 | 2012-11-20 | Anti-tumor effect potentiator |
| HK14109161.8A HK1195733A1 (zh) | 2009-11-30 | 2014-09-11 | 抗腫瘤效果增强劑 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK14109161.8A HK1195733A1 (zh) | 2009-11-30 | 2014-09-11 | 抗腫瘤效果增强劑 |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8883759B2 (ru) |
| EP (2) | EP2508185B1 (ru) |
| JP (1) | JP5336606B2 (ru) |
| KR (1) | KR101701549B1 (ru) |
| CN (2) | CN102612369B (ru) |
| AU (1) | AU2010323454B2 (ru) |
| BR (1) | BR112012013049A2 (ru) |
| CA (1) | CA2782280C (ru) |
| ES (2) | ES2788549T3 (ru) |
| HK (2) | HK1171185A1 (ru) |
| MX (1) | MX2012006183A (ru) |
| MY (1) | MY161094A (ru) |
| RU (1) | RU2548913C2 (ru) |
| TW (1) | TWI466870B (ru) |
| WO (1) | WO2011065541A1 (ru) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4688975B2 (ja) * | 2008-06-03 | 2011-05-25 | 大鵬薬品工業株式会社 | ヒトデオキシウリジントリホスファターゼ阻害活性を有する新規ウラシル化合物又はその塩 |
| CA2782280C (en) | 2009-11-30 | 2019-02-26 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor effect potentiator |
| WO2014107622A1 (en) * | 2013-01-07 | 2014-07-10 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| JP6513095B2 (ja) * | 2014-01-03 | 2019-05-15 | ユニバーシティ オブ サザン カリフォルニア | ヘテロ原子含有デオキシウリジントリホスファターゼ阻害剤 |
| EP3290038A4 (en) * | 2015-04-30 | 2018-12-26 | Taiho Pharmaceutical Co., Ltd. | Agent for alleviating adverse reaction to antitumor drug |
| CN107531646B (zh) | 2015-05-01 | 2020-11-03 | 大鹏药品工业株式会社 | 尿嘧啶化合物的结晶 |
| US10577321B2 (en) | 2015-07-08 | 2020-03-03 | University Of Southern California | Deoxyuridine triphosphatase inhibitors |
| US10544105B2 (en) | 2015-07-08 | 2020-01-28 | Cv6 Therapeutics (Ni) Limited | Deoxyuridine triphosphatase inhibitors containing cyclopropano linkage |
| EP3319939A1 (en) | 2015-07-08 | 2018-05-16 | CV6 Therapeutics (NI) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2017006271A1 (en) * | 2015-07-08 | 2017-01-12 | University Of Southern California | Deoxyuridine triphosphatase inhibitors containing amino sulfonyl linkage |
| CN106692173A (zh) * | 2015-11-18 | 2017-05-24 | 北京诺普德医药科技有限公司 | 一种抗肿瘤复方组合物及其应用 |
| AU2017205531B2 (en) * | 2016-01-08 | 2021-05-13 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor agent containing immunomodulator and anti-tumor effect potentiator |
| US11168059B2 (en) | 2016-11-23 | 2021-11-09 | Cv6 Therapeutics (Ni) Limited | Amino sulfonyl compounds |
| US11174271B2 (en) | 2016-11-23 | 2021-11-16 | Cv6 Therapeutics (Ni) Limited | 6-membered uracil isosteres |
| US10829457B2 (en) | 2016-11-23 | 2020-11-10 | Cv6 Therapeutics (Ni) Limited | Nitrogen ring linked deoxyuridine triphosphatase inhibitors |
| WO2018098207A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| WO2018098206A1 (en) | 2016-11-23 | 2018-05-31 | Cv6 Therapeutics (Ni) Limited | Hydantoin containing deoxyuridine triphosphatase inhibitors |
| US11247984B2 (en) | 2017-01-05 | 2022-02-15 | Cv6 Therapeutics (Ni) Limited | Uracil containing compounds |
| RU2706339C1 (ru) * | 2019-07-24 | 2019-11-18 | ФЕДЕРАЛЬНОЕ ГОСУДАРСТВЕННОЕ БЮДЖЕТНОЕ УЧРЕЖДЕНИЕ "РОССИЙСКИЙ НАУЧНЫЙ ЦЕНТР РАДИОЛОГИИ И ХИРУРГИЧЕСКИХ ТЕХНОЛОГИЙ ИМЕНИ АКАДЕМИКА А.М. ГРАНОВА" МИНИСТЕРСТВА ЗДРАВООХРАНЕНИЯ РОССИЙСКОЙ ФЕДЕРАЦИИ / ФГБУ "РНЦРХТ им. ак. А.М. Гранова" Минздрава России | Способ лечения операбельной аденокарциномы головки поджелудочной железы |
| JP2023040314A (ja) * | 2020-02-18 | 2023-03-23 | 大鵬薬品工業株式会社 | ウラシル誘導体化合物を含有する抗腫瘍効果増強剤 |
| AU2021297566A1 (en) | 2020-06-26 | 2023-01-19 | Cv6 Therapeutics (Ni) Limited | Combination therapy with deoxyuridine triphosphatase inhibitors |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5839672A (ja) * | 1981-09-03 | 1983-03-08 | Chugai Pharmaceut Co Ltd | ウラシル誘導体 |
| JPH09286786A (ja) * | 1996-04-18 | 1997-11-04 | Nippon Paper Ind Co Ltd | ピリミジン誘導体及びその抗腫瘍剤としての用途 |
| RU2102390C1 (ru) * | 1996-06-06 | 1998-01-20 | Научно-исследовательская лаборатория иммунохимиотерапии лепры и иммунотропных средств с клиникой и опытно-экспериментальным производством МЗМП России | N-(6-метил-2,4-диоксо-1,2,3,4-тетрагидропиримидинил-5-сульфонил) пиразин-2-карбоксамид, обладающий противолепрозной, противотуберкулезной и иммунотропной активностью, способ его получения |
| GB0400290D0 (en) * | 2004-01-08 | 2004-02-11 | Medivir Ab | dUTPase inhibitors |
| EP1939186A1 (en) * | 2006-12-22 | 2008-07-02 | Sulfidris S.r.l. | 5-Fluorouracil derivatives and their use for the treatment of cancer |
| JP4688975B2 (ja) | 2008-06-03 | 2011-05-25 | 大鵬薬品工業株式会社 | ヒトデオキシウリジントリホスファターゼ阻害活性を有する新規ウラシル化合物又はその塩 |
| JP2013032293A (ja) * | 2009-11-30 | 2013-02-14 | Taiho Yakuhin Kogyo Kk | ヒトｄＵＴＰａｓｅ阻害活性を有する５−フルオロウラシル化合物又はその塩 |
| CA2782280C (en) | 2009-11-30 | 2019-02-26 | Taiho Pharmaceutical Co., Ltd. | Anti-tumor effect potentiator |
| JP5839672B2 (ja) * | 2011-09-28 | 2016-01-06 | 株式会社日立製作所 | 低真空軟ｘ線実験装置 |
-
2010
- 2010-11-29 CA CA2782280A patent/CA2782280C/en active Active
- 2010-11-29 EP EP10833385.7A patent/EP2508185B1/en active Active
- 2010-11-29 AU AU2010323454A patent/AU2010323454B2/en not_active Ceased
- 2010-11-29 CN CN201080051775.1A patent/CN102612369B/zh active Active
- 2010-11-29 WO PCT/JP2010/071280 patent/WO2011065541A1/ja active Application Filing
- 2010-11-29 BR BR112012013049A patent/BR112012013049A2/pt not_active Application Discontinuation
- 2010-11-29 TW TW99141286A patent/TWI466870B/zh active
- 2010-11-29 MY MYPI2012002221A patent/MY161094A/en unknown
- 2010-11-29 EP EP20152282.8A patent/EP3673908B1/en active Active
- 2010-11-29 ES ES10833385T patent/ES2788549T3/es active Active
- 2010-11-29 RU RU2012127309/04A patent/RU2548913C2/ru active
- 2010-11-29 MX MX2012006183A patent/MX2012006183A/es active IP Right Grant
- 2010-11-29 US US13/509,102 patent/US8883759B2/en active Active
- 2010-11-29 ES ES20152282T patent/ES2906227T3/es active Active
- 2010-11-29 JP JP2011543351A patent/JP5336606B2/ja not_active Expired - Fee Related
- 2010-11-29 KR KR1020127013820A patent/KR101701549B1/ko active IP Right Grant
- 2010-11-29 CN CN201410177136.XA patent/CN103948599B/zh active Active
-
2012
- 2012-11-20 HK HK12111795.0A patent/HK1171185A1/xx unknown
-
2014
- 2014-09-11 HK HK14109161.8A patent/HK1195733A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| US20120225838A1 (en) | 2012-09-06 |
| CN103948599B (zh) | 2016-03-09 |
| ES2906227T3 (es) | 2022-04-13 |
| EP3673908A1 (en) | 2020-07-01 |
| AU2010323454B2 (en) | 2014-05-08 |
| TWI466870B (zh) | 2015-01-01 |
| EP2508185A1 (en) | 2012-10-10 |
| RU2548913C2 (ru) | 2015-04-20 |
| CA2782280A1 (en) | 2011-06-03 |
| RU2012127309A (ru) | 2014-01-10 |
| TW201124387A (en) | 2011-07-16 |
| MX2012006183A (es) | 2012-06-19 |
| ES2788549T3 (es) | 2020-10-21 |
| KR20120116925A (ko) | 2012-10-23 |
| US8883759B2 (en) | 2014-11-11 |
| CN102612369A (zh) | 2012-07-25 |
| MY161094A (en) | 2017-04-14 |
| CN102612369B (zh) | 2014-06-18 |
| EP3673908B1 (en) | 2022-01-12 |
| AU2010323454A1 (en) | 2012-06-21 |
| CN103948599A (zh) | 2014-07-30 |
| HK1195733A1 (zh) | 2014-11-21 |
| WO2011065541A1 (ja) | 2011-06-03 |
| JPWO2011065541A1 (ja) | 2013-04-18 |
| AU2010323454A2 (en) | 2012-06-14 |
| JP5336606B2 (ja) | 2013-11-06 |
| KR101701549B1 (ko) | 2017-02-01 |
| BR112012013049A2 (pt) | 2016-11-22 |
| EP2508185A4 (en) | 2016-05-25 |
| CA2782280C (en) | 2019-02-26 |
| EP2508185B1 (en) | 2020-03-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1195733A1 (zh) | 抗腫瘤效果增强劑 | |
| DK3023438T3 (en) | Anti-gitr-antistoffer | |
| DK2457337T3 (en) | Specialtilpasset impuls-burst | |
| EP2462514A4 (en) | GREEN BOOKS | |
| EP2443235A4 (en) | ß-glucosidase VARIANTS | |
| EP2515891A4 (en) | 3-keto-N-propargyl-1-aminoindan | |
| EP2508411A4 (en) | STRUCTURE | |
| EP2519921A4 (en) | CALL TRACING | |
| DK2464943T3 (en) | Systemintegration | |
| GB201011356D0 (en) | Ventalation arrangements | |
| GB0900568D0 (en) | Poymerisation | |
| GB0900319D0 (en) | Hydrocharger | |
| EP2510125A4 (en) | HYPER PRIMER | |
| AU4240P (en) | Tuckerbox xTriticosecale | |
| AU4924P (en) | Bonscablue Scaevola aemula | |
| AU4926P (en) | Bonscalib Scaevola aemula | |
| AU4925P (en) | Bonscawi Scaevola aemula | |
| TWM372073U (en) | Covering structure | |
| GB0900167D0 (en) | B b | |
| PL387107A1 (pl) | Profil | |
| GB0921748D0 (en) | Switch-actuated arrangements | |
| ZA201008616B (en) | Structure | |
| TWM386189U (en) | Hanging-painting structure | |
| TWM373647U (en) | Insect-trapping structure | |
| TWM371434U (en) | Sun-hat structure |